No results found.
Here are some suggested resources.
Articles
September 9, 2020
Pharmaceutical companies today are well-advised to view transparency as an opportunity to enhance their reputation in the marketplace and earn trust with stakeholders, which…
Articles
May 4, 2020
An article by Niamh McGuinness, Senior Analyst, CTT, Privacy Analytics Just over a year ago, Health Canada stipulated that all clinical trials documents needed…
Articles
April 15, 2020
A message from Sarah Lyons, General Manager, Privacy Analytics Privacy Analytics is wholly committed to the global effort to respond to COVID-19. We have…
Articles
November 21, 2019
An article by Sarah Lyons – Senior Director, Operations I recently heard something that stuck with me: “Nobody complies their way to greatness.” An…
Articles
September 26, 2019
An article by Sarah Lyons – Senior Director, Operations Should sponsors integrate risk-based anonymization across both documents and structured individual patient data (S-IPD)? The…
Articles
September 26, 2019
An article by Rachel Li, Senior Machine Learning Engineer, Privacy Analytics Unstructured data, such as medical notes, pose unique challenges with regards to anonymization. …